Viewing Study NCT05377034

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:38 AM
Ignite Modification Date: 2026-02-26 @ 1:00 AM
Study NCT ID: NCT05377034
Status: RECRUITING
Last Update Posted: 2025-10-06
First Post: 2022-05-11
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Multinational Phase II Trial to Compare Safety and Efficacy of SIRT (Y-90 Resin Microspheres) Followed by Atezolizumab Plus Bevacizumab, vs SIRT (SIRT-Y90) Followed by Placebo in Locally Advanced HCC Patients
Sponsor: National Cancer Centre, Singapore
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Locally Advanced Hepatocellular Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None SIRT-Y90 View
None Atezolizumab plus Bevacizumab View
None Hepatocellular Carcinoma View
None SIR-Sphere View